Serine and Methionine Metabolism: Vulnerabilities in Lethal Prostate Cancer

Area of Science:

• Oncology
• Metabolic pathways
• Cancer biology

Background:

• Altered cellular metabolism is a hallmark of both primary and recurrent cancers.
• Neuroendocrine prostate cancer (NEPC) is an aggressive, castration-resistant form of prostate cancer.
• Understanding the metabolic dependencies of NEPC is crucial for developing new treatments.

Purpose of the Study:

• To investigate the metabolic alterations in neuroendocrine prostate cancer.
• To identify specific metabolic pathways that are essential for NEPC survival and progression.
• To explore potential therapeutic vulnerabilities associated with these metabolic pathways.

Main Methods:

• Analysis of metabolic gene expression in NEPC patient samples.
• In vitro and in vivo studies to assess the role of specific metabolic networks.
• Metabolomic profiling to identify key metabolic alterations.

Main Results:

• Upregulation of the serine, glycine, one-carbon (SGOC) metabolic network was identified in NEPC.
• The SGOC network was found to be essential for the growth and survival of NEPC cells.
• Targeting the SGOC pathway demonstrated anti-tumor effects in preclinical models.

Conclusions:

• The serine, glycine, one-carbon metabolic network is a critical metabolic pathway in neuroendocrine prostate cancer.
• This metabolic network represents a targetable vulnerability for treating aggressive, castration-resistant prostate cancer.
• Further research into SGOC pathway inhibitors is warranted for NEPC therapy.